Advertisement

Children’s Cancer Cause Accepting Applications Through July 31 for 2022 Survivorship Champion’s Prize


Advertisement
Get Permission

The national advocacy group Children’s Cancer Cause, which plays a leadership role in advocacy and training on national issues affecting childhood cancer, has established an annual $10,000 award, the Survivorship Champion’s Prize, to be presented to a group, program, or institution making significant advances in programs and services to provide life-long health maintenance for survivors of pediatric cancers. The deadline to submit an application is July 31, 2022.

The award recognizes the importance of the unique challenges associated with the posttreatment services for survivors, especially as they transition to non-oncology adolescent and/or adult health care services.

Eligibility

Eligibility criteria include the following:

  • A group or institution based in the United States that advances pediatric cancer survivorship through programs and services that offer a sustainable process for maintaining health
  • Applicant must be, or be part of, a 501(c)(3) nonprofit institution or organization
  • Relevant work should be related to advancing cancer survivorship care services for children, adolescents, and young adults
  • The Prize recipient should have the ability to participate in a survivorship program hosted by Children’s Cancer Cause during the award year, such as an interview, advocacy event, webinar, or Capitol Hill briefing.

The Champion’s Prize will be presented as part of the Children’s Cancer Cause annual event in New York City in November 2022.

Established in 2020, the Survivorship Champion’s Prize has awarded a total of $50,000 in funds to prestigious survivorship programs around the country that are doing groundbreaking work to improve the long-term outlook for survivors.

To learn more, visit childrenscancercause.org.

The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
Advertisement

Advertisement



Advertisement